Next Generation News and Research

RSS

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm’s proprietary Ligand Activated Therapy (LAT) prodrug approach.

12 Jan 2010

Illumina launches HumanOmniExpress BeadChip for GWAS

Illumina, Inc. today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS).

From Illumina, Inc. 11 Jan 2010

Interest in studying psychology on the rise

"I hope I will be able to touch the lives of people when they most need help and to offer them advice and guidance."

9 Jan 2010

Los Alamos National Laboratory identifies 'Top 10 Laboratory science stories of 2009'

Los Alamos National Laboratory (www.lanl.gov) has identified the Top 10 Laboratory science stories of 2009 based on global viewership of online media content and major programmatic milestones.

9 Jan 2010

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Acetylon Pharmaceuticals, Inc. announced today that it has closed on a $2 million investment from a new undisclosed private investor to bring its total financing to $9.25 million. This new investment will convert to stock in the next substantial round of preferred equity financing.

9 Jan 2010

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUS® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.

9 Jan 2010

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Abbott announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V® Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

8 Jan 2010

Gore's next generation Conformable GORE TAG Thoracic Endoprosthesis enters clinical trial

W. L. Gore & Associates (Gore) announced the first human implants of the next generation Conformable GORE TAG® Thoracic Endoprosthesis in the United States for the treatment of traumatic transection of the thoracic aorta.

8 Jan 2010

Vignet releases Connected Health Services platform infrastructure for mHealth devices and services

Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new “person-centered” platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.

7 Jan 2010

SMART Modular Technologies releases XceedIOPS SATA

SMART Modular Technologies (WWH), Inc. ("SMART" or the "Company"), a leading independent manufacturer of memory modules and solid-state storage products, including solid-state drives (SSDs), today announced the XceedIOPS SATA, its next-generation enterprise-class SSD.

6 Jan 2010

Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Agilent Technologies, Inc. (NYSE:A) and Covaris Inc. today announced a co-marketing agreement in which Covaris S2 DNA shearing technology will be marketed with the Agilent SureSelect Target Enrichment System to streamline next-generation sequencing experiments.

6 Jan 2010

Innexus Biotechnology designs new psoriasis product

InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.

6 Jan 2010

UC San Diego bioengineering professor receives 2009 Presidential Science Prize

For Shu Chien - a pioneer in the growing field of bioengineering - understanding and learning the marvels of how the human body works has been the foundation of his decades-long quest to advance science and technology worldwide. The UC San Diego bioengineering professor's significant scientific endeavors have paved the way for recognition of his renowned work at the university's Jacobs School of Engineering and abroad.

6 Jan 2010

OncoMed Pharmaceuticals and Fluidigm announce new initiative to analyze tumor cell heterogeneity

OncoMed Pharmaceuticals, Inc. and Fluidigm Corporation today announced a new initiative to apply Fluidigm's unique microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells.

6 Jan 2010

Scientists develop mucus-penetrating biodegradable nanoparticles to deliver drugs over time

Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release medication cargo.

5 Jan 2010

Ford and MIT explore automotive technology solutions to reduce driver stress

As Americans fight through the most stressful time of the year, Ford Motor Company and the Massachusetts Institute of Technology (MIT) are embarking on a plan to study driver workload and identify new opportunities to use in-vehicle technologies to improve driver safety by lowering stress.

31 Dec 2009

VIVUS submits a NDA to the FDA for obesity drug Qnexa

VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.

30 Dec 2009

NeurAxon closes the sale of $8.75 million of unsecured subordinated convertible debentures

NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed the sale of approximately $8.75 million of unsecured subordinated 2.0% convertible debentures that are convertible under specified circumstances into existing class B preferred shares.

29 Dec 2009

Senate health care bill will increase patient access and help create high-wage, high-value jobs

“These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation’s burgeoning biotech sector and help maintain U.S. global leadership in innovation.”

28 Dec 2009

Bristol-Myers Squibb updates its 2009 guidance for GAAP and non-GAAP earnings

Bristol-Myers Squibb Company today updated its 2009 guidance for GAAP and non-GAAP earnings per share from continuing operations.

24 Dec 2009

Next Generation News and Research

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

Illumina launches HumanOmniExpress BeadChip for GWAS

Interest in studying psychology on the rise

Los Alamos National Laboratory identifies 'Top 10 Laboratory science stories of 2009'

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Gore's next generation Conformable GORE TAG Thoracic Endoprosthesis enters clinical trial

Vignet releases Connected Health Services platform infrastructure for mHealth devices and services

SMART Modular Technologies releases XceedIOPS SATA

Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Innexus Biotechnology designs new psoriasis product

UC San Diego bioengineering professor receives 2009 Presidential Science Prize

OncoMed Pharmaceuticals and Fluidigm announce new initiative to analyze tumor cell heterogeneity

Scientists develop mucus-penetrating biodegradable nanoparticles to deliver drugs over time

Ford and MIT explore automotive technology solutions to reduce driver stress

VIVUS submits a NDA to the FDA for obesity drug Qnexa

NeurAxon closes the sale of $8.75 million of unsecured subordinated convertible debentures

Senate health care bill will increase patient access and help create high-wage, high-value jobs

Bristol-Myers Squibb updates its 2009 guidance for GAAP and non-GAAP earnings

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News